TB-resistant cows developed for first time using gene editing

Image
Press Trust of India Beijing
Last Updated : Feb 01 2017 | 12:32 PM IST
Chinese scientists have used gene-editing technology CRISPR/Cas9 for the first time to successfully produce live cows with increased resistance to bovine tuberculosis.
The researchers, from Northwest A&F University in China, used a modified version of the CRISPR gene-editing technology to insert a new gene into the cow genome with no detected off target effects on the animals genetics - a common problem when creating transgenic animals using CRISPR.
"We used a novel version of the CRISPR system called CRISPR/Cas9n to successfully insert a tuberculosis resistance gene, called NRAMP1, into the cow genome," lead researcher Yong Zhang said.
"We were then able to successfully develop live cows carrying increased resistance to tuberculosis. Importantly, our method produced no off target effects on the cow genetics meaning that the CRISPR technology we employed may be better suited to producing transgenic livestock with purposefully manipulated genetics," said Zhang.
CRISPR technology has become widely used in the laboratory in recent years as it is an accurate and relatively easy way to modify the genetic code.
However, sometimes unintentional changes to the genetic code occur as an off target effect, so finding ways to reduce these is a priority for genomics research.
"We employed a meticulous and methodological approach to identify the best suited region for gene insertion, which we show has no detectable off target effects on the bovine genome," Zhang said.
The researchers inserted the NRAMP1 gene into the genome of bovine foetal fibroblasts - a cell derived from female dairy cows-using the CRISPR/Cas9n technology.
These cells were then used as donor cells in a process called somatic cell nuclear transfer, where the nucleus of a donor cell carrying the new gene is inserted into an egg cell, known as an ovum, from a female cow.
Ova were nurtured in the lab into embryos before being transferred into mother cows for a normal pregnancy cycle. The experiments were also conducted using the standard CRISPR/Cas9 technology as a comparison.
The total of 11 calves with new genes inserted using CRISPR were able to be assessed for resistance to tuberculosis and any off target genetic effects.
Genetic analysis of the calves revealed that NRAMP1 had successfully integrated into the genetic code at the targeted region in all of the calves.
None of the calves that had the gene inserted using the new CRISPR/Cas9n technology had any detectable off target effects whereas all of the calves with the gene inserted with previously used techniques for CRISPR/Cas9 did.
When the calves were exposed to M bovis, the bacterium that causes bovine tuberculosis, the researchers found that transgenic animals showed an increased resistance to bacteria measured by standard markers of infection in a blood sample.
The research was published in the journal Genome Biology.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 01 2017 | 12:32 PM IST

Next Story